1 / 53

Kimberly Salkey, M.D. Department of Dermatology Eastern Virginia Medical School

Clinical Pearls: Dermatologic Findings of Nails and Hair American College of Physicians 2013 Virginia Chapter Annual Meeting and Clinical Update. Kimberly Salkey, M.D. Department of Dermatology Eastern Virginia Medical School. I have no conflicts of interest to declare. Patient 1.

antonie
Download Presentation

Kimberly Salkey, M.D. Department of Dermatology Eastern Virginia Medical School

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Pearls: Dermatologic Findings of Nails and Hair American College of Physicians2013 Virginia Chapter Annual Meetingand Clinical Update Kimberly Salkey, M.D. Department of Dermatology Eastern Virginia Medical School

  2. I have no conflicts of interest to declare

  3. Patient 1 Chief Complaint: Hair loss

  4. Patient 1 • History • Excessive shedding • Smaller ponytail • Just married 3 months ago • Examination • Diffuse ↓ in hair density • Scalp, brows, lashes WNL • Hair pull positive

  5. Telogen Effluvium • Excessive and early entry of hairs into the telogen phase • Triggered by emotionally or physiologically stressful events • Shedding begins 2-4 months after trigger • > 25% of hairs in telogen phase • Hair loss can approach 400-500/day

  6. Human Hair Cycle

  7. Up to 100 scalp hairs shed/day 100,000 scalp hairs Few months 2-7 years 90% 10%

  8. Telogen Effluvium

  9. Childbirth Severe infection Severe chronic illness Severe psychological stress Major surgery Hypo or hyperthyroidism Crash diets inadequate protein Drugs Causes of Telogen Effluvium

  10. Management of Telogen Effluvium • Laboratory evaluation • Directed by history • Thyroid studies, CBC, Iron studies • Check medications • βblockers, NSAIDS, anti-coagulants, HRT • Reassurance • Reassurance • Minoxidil

  11. Clinical Pearl • Acute onset, diffuse hair shedding occurring a few months after a major stressor • Identify cause • Offer reassurance re: self limited course Telogen Effluvium

  12. Patient 2 Chief Complaint: Toe nail discoloration

  13. Patient 2 • History • Discoloration for years • Itchy feet • Healthy • No skin disease • Examination • Similar findings on both feet

  14. Onychomycosis • AKA tinea unguium • 3 types • Distal/lateral subungual • Most common • White superficial • Direct invasion of superficial nail plate • Proximal subungual • Immunocompromised hosts

  15. Onychomycosis

  16. Onychomycosis

  17. Onychomycosis

  18. Onychomycosis • White spotting due to superficial dermatophyte infection or trauma

  19. Onychomycosis Evaluation and Treatment • Culture to confirm diagnosis • Terbinafine 250mg PO qd • Fingernails- 6 weeks • Toenails- 12 weeks • Itraconazole • 200 mg PO qd x 12 weeks OR • 200 mg BID x 1 week/month for 3-4 consecutive months • Griseofulvin • Fluconazole • Ciclopirox nail lacquer

  20. Clinical Pearl:Onychomycosis • Confirm diagnosis • Patient education • Frequent recurrence • Potential side effects of treatment

  21. Patient 3 Chief Complaint: Hair loss

  22. Patient 3 • History • Abrupt onset • Gradually enlarging • Otherwise well, cousin with vitiligo • Examination • Sharply demarcated round patch of alopecia • Hair pull positive at periphery • “shaggy” pits in the fingernails

  23. Alopecia Areata • Autoimmune disorder • Acute onset • Well circumscribed, round or oval patches • Males=females

  24. N Engl J Med 2012;366:1515-25.

  25. N Engl J Med 2012;366:1515-25.

  26. Alopecia Areata

  27. Alopecia Areata • Diagnosis • Usually based on clinical findings • Skin biopsy: lymphocytic infiltrate surrounds early anagen hair bulbs “swarm of bees” • Treatment • Topical, intralesional corticosteroids • Oral steroids • CAUTION: may experience hair loss after discontinuation • Immunotherapy • Phototherapy • Cyclosporine and Methotrexate will

  28. Alopecia Areata • Variable course • Relapses occur • Poor prognosis • Duration more than one year • Extensive hair loss • Onset at age <5 years • Family history of alopecia areata

  29. Clinical Pearl:Alopecia Areata • Acute onset • Well defined • Oval or round patches of alopecia Gold Standard:Intralesional kenalog

  30. Patient 4 N ENGL J MED 2011; 364:E38 Chief Complaint: Toe nail discoloration

  31. Patient 4 • History • 37yo man • 4 year history of gradual darkening and widening of pigmented band • Examination • Brown/Black extension to proximal nail fold- Hutchinson’s sign N ENGL J MED 2011; 364:E38

  32. Palm, sole or nail bed Median age 65 50-70% of melanomas in African Americans and Asians Acral Lentiginous Melanoma

  33. Minocycline Anti-malarials Gold

  34. Nail matrix nevus

  35. Nail matrix nevus

  36. A patient with HIV taking zidovudine

  37. Subungual hematoma

  38. Pseudomonas nail infection

  39. Clinical Pearl:Melanonychia • Check for Hutchinson’s sign- extension of pigment to proximal nail fold • If negative, consider • Normal variant • Traumatic • Drug induced

  40. Patient 5 Chief Complaint: Hair loss

  41. Patient 5 • History • Gradually thinning on top since age 20’s • Dad’s hair also thin • No known medical problems • Examination • ↓↓ density of frontal scalp with recession of frontal hair line • Many miniaturized hairs

  42. Androgenetic Alopecia-MEN • 50% by age 50 years • Androgen dependent progressive decline in anagen duration • Genetic predisposition • Hair follicles miniaturize • Hair loss occurs in the fronto-temporal regions and the vertex Uptake, metabolism, and conversion of testosterone to dihydrotestosterone by 5-alpha-reductase is increased in balding hair follicles.

  43. Androgenetic Alopecia

  44. Female Pattern Hair Loss Androgenetic Alopecia • WOMEN • With or without androgen excess • Early or late onset • Hairs of variable diameter • Top of scalp most significantly involved

  45. Female Pattern Hair Loss

  46. Androgenetic Alopecia • Progressive shortening of successive anagen cycles • Miniaturization

  47. Androgenetic Alopecia Ludwig Hamilton-Norwood

More Related